These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6113210)

  • 1. Pain response following insertion of a Gravigard (Copper-7) intrauterine contraceptive device in nulliparous women.
    Goldstuck ND
    Int J Fertil; 1981; 26(1):53-6. PubMed ID: 6113210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the actual and expected pain response following insertion of an intrauterine contraceptive device.
    Goldstuck ND; Matthews ML
    Clin Reprod Fertil; 1985 Mar; 3(1):65-71. PubMed ID: 3978537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil.
    Lassner KJ; Chen CH; Kropsch LA; Oberle MW; Lopes IM; Morris L
    Bull Pan Am Health Organ; 1995 Sep; 29(3):206-15. PubMed ID: 8520606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of a modified copper intrauterine device in nulliparous women with small uterine axial length.
    Goldstuck ND
    J Reprod Med; 1980 Oct; 25(4):183-6. PubMed ID: 7431367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Gravigard intrauterine copper contraceptive device.
    Macourt DC
    Med J Aust; 1974 May; 1(18):717-8. PubMed ID: 4851932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
    Wildemeersch D; Janssens D; Vrijens M; Weyers S
    Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device?
    Neale R; Knight I; Keane F
    Int J STD AIDS; 2009 Jun; 20(6):423-4. PubMed ID: 19451330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nova-T 200 intrauterine contraceptive device: a 12 year study.
    Baeyertz JD; Hartfield VJ
    N Z Med J; 1997 May; 110(1043):169-71. PubMed ID: 9196502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the initial pain response following insertion of the Copper 7 and combined Multiload Copper 250-short IUDs.
    Goldstuck ND
    Contracept Deliv Syst; 1981 Oct; 2(4):295-301. PubMed ID: 12336990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial.
    Sääv I; Aronsson A; Marions L; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2007 Oct; 22(10):2647-52. PubMed ID: 17652452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper intrauterine device use by nulliparous women: review of side effects.
    Hubacher D
    Contraception; 2007 Jun; 75(6 Suppl):S8-11. PubMed ID: 17531622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen.
    Hubacher D; Reyes V; Lillo S; Zepeda A; Chen PL; Croxatto H
    Am J Obstet Gynecol; 2006 Nov; 195(5):1272-7. PubMed ID: 17074548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intrauterine contraception with copper-T 200 device- a retrospective analysis of 334 cases (author's transl)].
    Salzer H; Schneider WH; Eppel W
    Wien Klin Wochenschr; 1981 May; 93(11):354-8. PubMed ID: 7269615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of side-effects of Cu-T as intra-uterine contraceptive device in post medical termination of pregnancy and interval cases.
    Das CR; Pradhan G
    J Indian Med Assoc; 1995 Oct; 93(10):375-6. PubMed ID: 9053409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New Zealand.
    Harrison-Woolrych M; Zhou L; Coulter D
    N Z Med J; 2003 Aug; 116(1179):U538. PubMed ID: 14513085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting the intrauterine contraceptive device in adolescents.
    Toma A; Jamieson MA
    J Pediatr Adolesc Gynecol; 2006 Aug; 19(4):291-6. PubMed ID: 16873034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous eruptions and intrauterine contraceptive copper device.
    Frentz G; Teilum D
    Acta Derm Venereol; 1980; 60(1):69-71. PubMed ID: 6153839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.